Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer Patient”

1,802 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,802 results

Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Large-scale testing (Phase 3)UnknownNCT02409199
What this trial is testing

Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Carcinoma
Shanghai Zhongshan Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT05671822
What this trial is testing

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer

Who this might be right for
HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 258
Testing effectiveness (Phase 2)UnknownNCT04943653
What this trial is testing

Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Stomach NeoplasmsPaclitaxelPeritoneal Metastases
Seoul St. Mary's Hospital 61
Testing effectiveness (Phase 2)Looking for participantsNCT07176312
What this trial is testing

Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) Patients

Who this might be right for
Gastroesophageal AdenocarcinomaFirst Line TherapyHER2 + Gastric Cancer+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 80
Not applicableActive Not RecruitingNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Testing effectiveness (Phase 2)Study completedNCT00375999
What this trial is testing

Docetaxel and Epirubicin in Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Yonsei University 34
Large-scale testing (Phase 3)Study completedNCT02988635
What this trial is testing

Early Palliative Care on Quality of Life of Advanced Cancer Patients

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Cancer+1 more
Azienda Ospedaliero-Universitaria di Parma 281
Testing effectiveness (Phase 2)Study completedNCT02689284
What this trial is testing

Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerStomach CancerEsophageal Cancer
MacroGenics 95
Not applicableActive Not RecruitingNCT04084249
What this trial is testing

CtDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

Who this might be right for
Colorectal CancerColo-rectal CancerctDNA+12 more
Claus Lindbjerg Andersen 359
Large-scale testing (Phase 3)Active Not RecruitingNCT04919226
What this trial is testing

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 259
Testing effectiveness (Phase 2)Study completedNCT01338948
What this trial is testing

Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients

Who this might be right for
Gastric Cancer
Yonsei University 12
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Not applicableNot Yet RecruitingNCT07237126
What this trial is testing

Single-port Robotic Radical Gastrectomy for Gastric Cancer

Who this might be right for
Gastric Cancer Patients Undergoing Gastrectomy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 20
Not applicableUnknownNCT01863420
What this trial is testing

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

Who this might be right for
Rectal CancerGastric CancerBone Marrow Toxicity+1 more
Chinese Academy of Medical Sciences 58
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Testing effectiveness (Phase 2)Looking for participantsNCT05438420
What this trial is testing

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerHepatocellular Cancer+1 more
Qurient Co., Ltd. 120
Large-scale testing (Phase 3)Active Not RecruitingNCT03348150
What this trial is testing

Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.

Who this might be right for
Stomach NeoplasmPeritoneal Carcinomatosis
The Netherlands Cancer Institute 102
Not applicableStudy completedNCT03017690
What this trial is testing

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 22
Not applicableStudy completedNCT01920113
What this trial is testing

A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil

Who this might be right for
Early Gastric Cancer Patients Who Were Scheduled for Endoscopic Submucosal Dissection
Yonsei University 60
Load More Results